Your browser doesn't support javascript.
loading
Safety and immunogenicity of an inactivated virus particle vaccine for SARS-CoV-2, BIV1-CovIran: findings from double-blind, randomised, placebo-controlled, phase I and II clinical trials among healthy adults.
Mohraz, Minoo; Salehi, Mohammadreza; Tabarsi, Payam; Abbasi-Kangevari, Mohsen; Ghamari, Seyyed-Hadi; Ghasemi, Erfan; Amini Pouya, Maryam; Rezaei, Negar; Ahmadi, Naser; Heidari, Kazem; Malekpour, Mohammad-Reza; Nasiri, Mojtaba; Amirzargar, Ali Akbar; Saeedi Moghaddam, Sahar; Larijani, Bagher; Hosseini, Hamed.
Afiliação
  • Mohraz M; Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.
  • Salehi M; Department of Infectious Diseases and Tropical Medicine, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
  • Tabarsi P; Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Disease, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Abbasi-Kangevari M; Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Ghamari SH; Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Ghasemi E; Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Amini Pouya M; Department of Pharmaceutics, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
  • Rezaei N; Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Ahmadi N; Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Heidari K; Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Malekpour MR; Clinical Trial Center (CTC), Tehran University of Medical Sciences, Tehran, Iran.
  • Nasiri M; Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Amirzargar AA; Clinical Trial Center (CTC), Tehran University of Medical Sciences, Tehran, Iran.
  • Saeedi Moghaddam S; Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Larijani B; Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Hosseini H; Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
BMJ Open ; 12(4): e056872, 2022 04 08.
Article em En | MEDLINE | ID: mdl-35396297
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adolescent / Adult / Aged / Humans / Middle aged Idioma: En Revista: BMJ Open Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Irã País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adolescent / Adult / Aged / Humans / Middle aged Idioma: En Revista: BMJ Open Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Irã País de publicação: Reino Unido